source
- FDA schedules first oncology advisory panel in nine months, will review AstraZeneca candidatesThe FDA announced it will hold an oncology advisory committee meeting roughly nine months from now. The meeting will focus on evaluating a pair of investigational drugs from AstraZeneca, though de…
- Health AI discourse shifts from hype to practical discussion, says STAT newsletterBrittany Trang, a health‑tech reporter at STAT, reflects on how the conversation around artificial intelligence in healthcare is changing. In her AI Prognosis newsletter she notes that the industry…